ImmuPharma agrees £50 financing
ImmuPharma - the specialist drug discovery and development company - has secured a £50m, five -year equity financing facility with Darwin Strategi to fund ImmuPharma's late stage Lupuzor compound.
ImmuPharma says the £50m facility allows it to complete the last development stage, phase III - of its blockbuster Lupuzor compound while continuing discussions with major pharmaceutical companies for a potential corporate deal.
Open a free research account
|Bid / Ask||124 / 125.5|
|Day Range||111.5 / 127|
|52Week Range||43.44 / 193.00|
|Last Update: 16:21:32 (23/03/18)|